Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Withdrawn 1Unknown 1Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6Sarcoma 1

Conditions

Ovarian Neoplasms 1773Uterine Cervical Neoplasms 1499Endometrial Neoplasms 833Breast Neoplasms 434Carcinoma, Ovarian Epithelial 405Fallopian Tube Neoplasms 399Uterine Cervical Dysplasia 276Neoplasms 252Colorectal Neoplasms 179Uterine Neoplasms 173Peritoneal Neoplasms 170Vulvar Neoplasms 155Lung Neoplasms 150Pancreatic Neoplasms 141Prostatic Neoplasms 135Recurrence 128Stomach Neoplasms 126Colonic Neoplasms 116Papillomavirus Infections 115Melanoma 101Sarcoma 97Urinary Bladder Neoplasms 95Vaginal Neoplasms 93Carcinoma, Non-Small-Cell Lung 92Head and Neck Neoplasms 91Neoplasm Metastasis 83Esophageal Neoplasms 82Testicular Neoplasms 80Rectal Neoplasms 71Kidney Neoplasms 62

Interventions

niraparib 3pembrolizumab 1Paclitaxel 1Diphenhydramine 1Dexamethasone 1Cimetidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Cystadenocarcinoma, Serous × Gynecologic × Clear all
NCT04159155 2025-08-12

CAN-STAMP

University Health Network, Toronto

Phase 2/3 Terminated
11 enrolled
Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04575961 2025-05-23

PERCEPTION

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting
33 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT05289648 2024-12-19

NIREC

Sir Mortimer B. Davis - Jewish General Hospital

Phase EARLY_PHASE1 Withdrawn
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04716686 2024-01-05

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Shandong University

Phase 2 Recruiting
83 enrolled
Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04055038 2019-08-13

EPITOC

Blokhin's Russian Cancer Research Center

Phase 2/3 Unknown
164 enrolled
Gynecologic

Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled 5 charts
Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡